Published in Circulation on November 07, 2000
Engineering complex tissues. Tissue Eng (2006) 2.53
Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials (2008) 1.57
Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng (2006) 1.26
Electrospun scaffolds for tissue engineering of vascular grafts. Acta Biomater (2013) 1.17
Cardiac tissue engineering for replacement therapy. Heart Fail Rev (2003) 1.09
Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. J Cell Mol Med (2010) 0.99
Mechanical evaluation of decellularized porcine thoracic aorta. J Surg Res (2011) 0.94
Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philos Trans R Soc Lond B Biol Sci (2007) 0.92
EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology. J Cardiovasc Transl Res (2011) 0.91
Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol (2011) 0.90
Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials. Acta Biomater (2011) 0.90
Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials (2008) 0.88
Decellularization of human dermis using non-denaturing anionic detergent and endonuclease: a review. Cell Tissue Bank (2014) 0.88
Future prospects for tissue engineered lung transplantation: decellularization and recellularization-based whole lung regeneration. Organogenesis (2014) 0.86
Biomechanical and structural changes following the decellularization of bovine pericardial tissues for use as a tissue engineering scaffold. J Mater Sci Mater Med (2012) 0.84
Decellularized ureter for tissue-engineered small-caliber vascular graft. J Artif Organs (2008) 0.84
Preparation of in-vivo tissue-engineered valved conduit with the sinus of Valsalva (type IV biovalve). J Artif Organs (2010) 0.84
New technologies for surgery of the congenital cardiac defect. Rambam Maimonides Med J (2013) 0.83
Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering. J Healthc Eng (2012) 0.81
Decellularized allogeneic heart valves demonstrate self-regeneration potential after a long-term preclinical evaluation. PLoS One (2014) 0.81
Differentiation and Distribution of Marrow Stem Cells in Flex-Flow Environments Demonstrate Support of the Valvular Phenotype. PLoS One (2015) 0.81
Alternatives to animal testing: A review. Saudi Pharm J (2013) 0.80
Heart Valve Replacements with Regenerative Capacity. Transfus Med Hemother (2016) 0.80
Cardiac valve cells and their microenvironment--insights from in vitro studies. Nat Rev Cardiol (2014) 0.79
Comparison of Mesenchymal Stem Cell Source Differentiation Toward Human Pediatric Aortic Valve Interstitial Cells within 3D Engineered Matrices. Tissue Eng Part C Methods (2015) 0.79
Tissue engineering of heart valves: PEGylation of decellularized porcine aortic valve as a scaffold for in vitro recellularization. Biomed Eng Online (2013) 0.78
Angiogenic response induced by acellular femoral matrix in vivo. J Anat (2005) 0.78
A novel porcine acellular dermal matrix scaffold used in periodontal regeneration. Int J Oral Sci (2013) 0.78
Mechanocompatible Polymer-Extracellular-Matrix Composites for Vascular Tissue Engineering. Adv Healthc Mater (2016) 0.77
Tissue engineered scaffolds for an effective healing and regeneration: reviewing orthotopic studies. Biomed Res Int (2014) 0.77
Synergistic effect of fibronectin and hepatocyte growth factor on stable cell-matrix adhesion, re-endothelialization, and reconstitution in developing tissue-engineered heart valves. Heart Vessels (2007) 0.77
Application of hydrogels in heart valve tissue engineering. J Long Term Eff Med Implants (2015) 0.75
Decellularized Tooth Bud Scaffolds for Tooth Regeneration. J Dent Res (2017) 0.75
Around PediHeart: bioprosthesis failure. Pediatr Cardiol (2001) 0.75
Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularization. Sci Rep (2017) 0.75
Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39
Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg (1996) 3.77
Intramural hemorrhage of the thoracic aorta. Diagnostic and therapeutic implications. Circulation (1995) 3.50
Attitude of patients toward transplantation of xenogeneic organs. Langenbecks Arch Surg (1999) 2.19
Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet (1998) 2.06
Coronary artery bypass grafting surgery without the routine application of blood products: Is it feasible? Eur J Cardiothorac Surg (2001) 2.02
Successful lung transplantation for posttraumatic adult respiratory distress syndrome after extracorporeal membrane oxygenation support. J Heart Lung Transplant (1992) 1.93
Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant (2010) 1.87
Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches. Circulation (1991) 1.83
EuroSCORE overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol (2009) 1.81
Monophasic action potential mapping in human subjects with normal electrocardiograms: direct evidence for the genesis of the T wave. Circulation (1987) 1.81
Ultraviolet protection by summer textiles. Ultraviolet transmission measurements verified by determination of the minimal erythema dose with solar-simulated radiation. Br J Dermatol (2001) 1.81
Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res (1988) 1.77
Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart (2003) 1.76
Different approaches for minimally invasive closure of atrial septal defects. Ann Thorac Surg (1999) 1.75
Repression of glycoprotein synthesis and release of surface coat during transformation of Trypanosoma brucei. EMBO J (1983) 1.62
Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61
Myocardial calcification after orthotopic heart transplantation. J Heart Transplant (1988) 1.53
Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Am J Transplant (2013) 1.49
Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery. J Thorac Cardiovasc Surg (2006) 1.48
Bronchial circulation after experimental lung transplantation. The effect of long-term administration of prednisolone. J Thorac Cardiovasc Surg (1993) 1.47
Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant (2001) 1.47
A new minimally invasive approach to the subclavian artery. Ann Thorac Surg (1998) 1.46
Clinical evaluation of transtracheal Doppler for continuous cardiac output estimation. Anesth Analg (1992) 1.45
Therapy for lung failure using nitric oxide inhalation and surfactant replacement. Ann Thorac Surg (1996) 1.45
Cardiac surgery in Germany during 2008. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg (2009) 1.45
Ten year survival after heart transplantation: palliative procedure or successful long term treatment? Heart (1999) 1.43
Matched-pair analysis of conventional versus endoluminal AAA treatment outcomes during the initial phase of an aortic endografting program. J Endovasc Ther (2000) 1.40
Coarctation of the aorta in complex congenital heart disease: simultaneous repair via sternotomy. Eur J Cardiothorac Surg (1990) 1.39
Hyperacute rejection in heart allografts. Case studies. Pathol Res Pract (1991) 1.39
Retrograde versus antegrade crystalloid cardioplegia in coronary surgery: value of troponin-I measurement. Ann Thorac Surg (2001) 1.39
Preoperative corticosteroids. A contraindication to lung transplantation? Chest (1992) 1.39
[Extravasal position of central venous catheters despite unsuspicious ECG-guidance]. Anasthesiol Intensivmed Notfallmed Schmerzther (2005) 1.39
Explantation of the heart for resection of primary cardiac tumors can be avoided by partial ex situ heart surgery. Thorac Cardiovasc Surg (2003) 1.39
Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metab Dispos (1995) 1.39
Rapid identification of viral infections in liver, heart, and kidney allograft biopsies by in situ hybridization. Am J Surg Pathol (1989) 1.38
Tissue engineering of heart valves--human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg (1998) 1.36
Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation (2000) 1.25
Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth (2009) 1.24
Chronic hepatitis e in heart transplant recipients. Am J Transplant (2012) 1.18
Site of pleural drain insertion and early postoperative pulmonary function following coronary artery bypass grafting with internal mammary artery. Chest (1999) 1.18
Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant (2009) 1.15
Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg (1999) 1.15
Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis (2010) 1.13
Guided tissue regeneration of vascular grafts in the peritoneal cavity. Circ Res (2002) 1.12
Transposition of the greater omentum for management of mediastinal infection following orthotopic heart transplantation: a case report. J Heart Transplant (1987) 1.11
Fibrin adhesive: an important hemostatic adjunct in cardiovascular operations. J Thorac Cardiovasc Surg (1982) 1.09
Bronchoalveolar lavage in lung transplantation. State of the art. Clin Transplant (1999) 1.08
[Allergies to animal hair in diseases of the upper respiratory tract (author's transl)]. Dtsch Med Wochenschr (1975) 1.08
Impact of preoperative aortic root diameter on long-term aortic valve function after valve sparing aortic root reimplantation. Circulation (2003) 1.06
Inflammatory bowel disease in children and young adults: correlation of sonographic and clinical parameters during treatment. AJR Am J Roentgenol (2000) 1.05
Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders. J Clin Microbiol (2001) 1.05
Acute and chronic aortic dissections--determinants of long-term outcome for operative survivors. Circulation (1985) 1.04
Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant (2011) 1.04
Central venous catheters--the inability of 'intra-atrial ECG' to prove adequate positioning. Br J Anaesth (2004) 1.04
Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng (2000) 1.03
A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions. Biotechnol Prog (2000) 1.02
Shuttle of lentiviral vectors via transplanted cells in vivo. Gene Ther (2005) 1.02
Impact of oxygen environment on mesenchymal stem cell expansion and chondrogenic differentiation. Cell Prolif (2009) 1.01
Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. Circ Res (1992) 1.01
Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides. Eur J Vasc Endovasc Surg (1996) 1.00
Hepatic tissue culture model for study of host-parasite interactions in alveolar echinococcosis. Infect Immun (1996) 0.99
Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochem Pharmacol (1997) 0.98
The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential. J Immunol (1988) 0.98
Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg (2001) 0.97
Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int (1998) 0.97
Laser printing of cells into 3D scaffolds. Biofabrication (2010) 0.97
Low oxygen expansion improves subsequent chondrogenesis of ovine bone-marrow-derived mesenchymal stem cells in collagen type I hydrogel. Cells Tissues Organs (2008) 0.97
Effects of minimal invasive coronary artery bypass on pulmonary function and postoperative pain. Ann Thorac Surg (2000) 0.97
Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo. Biochem J (1997) 0.97
Surgical treatment of active infective endocarditis with paravalvular involvement. J Thorac Cardiovasc Surg (1994) 0.97
Tempromandibular joint (TMJ) response to intra-articular dexamethasone injection following mechanical arthropathy: a histological study in rats. Int J Oral Maxillofac Surg (2005) 0.96
Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg (2000) 0.96
Predictors of proximal aortic dissection at the time of aortic valve replacement. Circulation (1999) 0.96
Regulation of lineage-specific transcription of the sucrase-isomaltase gene in transgenic mice and cell lines. Am J Physiol (1995) 0.96
Proximal aortic dissection late after aortic valve surgery: 119 cases of a distinct clinical entity. Thorac Cardiovasc Surg (2000) 0.96
Immunosuppressive therapy after human lung transplantation. Eur Respir J (2004) 0.96
Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Transplant Proc (1998) 0.96
Microcirculation of the sternum following harvesting of the left internal mammary artery. Thorac Cardiovasc Surg (2003) 0.95
Video-assisted minimally invasive approach in clinical bilateral lung transplantation. J Thorac Cardiovasc Surg (2001) 0.95
Traumatic posterior atlantoaxial dislocation without neurological deficit: case report. Neurosurgery (1983) 0.95
Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology (1995) 0.95
Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials (2003) 0.95
In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg (2002) 0.94
Retroviral infection and expression of cationic amino acid transporters in rodent hepatocytes. J Virol (1993) 0.94
Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation (2000) 0.93
A serine phosphatase is involved in CD2-mediated activation of human T lymphocytes and natural killer cells. J Immunol (1991) 0.93
Single-channel properties of L-type calcium channels from failing human ventricle. Cardiovasc Res (1998) 0.93
Status of patients presently living 9 to 13 years after orthotopic heart transplantation. Ann Thorac Surg (1997) 0.93
A single-fiber in vitro motility assay. In vitro sliding velocity of F-actin vs. unloaded shortening velocity in skinned muscle fibers. J Muscle Res Cell Motil (1999) 0.92